|Dr Reddys Laboratories Limited -- USA Stock|| |
USD 33.17 1.24 3.88%
Executive Vice President Head - North America Generics
Mr. Umang Vohra is Executive Vice President Head North America Generics of Dr. Reddy Laboratories Ltd since January 2013. He resigned as Chief Financial Officer of the company effective January 2 2013. He has over 14 years of experience across various functions within finance strategic planning and corporate development. He is responsible for managing Company organizations global finance functions including among others Accounts and Controlling Taxation Compliance Secretarial Investor Relations and Treasury. He joined the Company in 2002 initially working as Deputy Chief Financial Officer and was part of several of Company key initiatives like acquisitions research and development derisking transactions and operational improvements and migration to IFRS in Company accounting governance and finance processes. Prior to joining the Company Mr. Vohra worked with Eicher and PepsiCo India
Age: 43 President Since 2013 MBA
91 40 4900 2900 http://www.drreddys.com
Vohra has a base degree in computer engineering and he holds an MBA with a specialization in Finance from TA Pai Institute of Management, India.
The company has Return on Asset of 3.65 %
which means that on every $100 spent on asset it made $3.65 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE)
of 8.1 %
implying that it generated $8.1 on every 100 dollars invested.
The company has 846.73 M in debt with debt to equity (D/E) ratio of 44.4 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories Limited has Current Ratio of 1.47 which is typical for the industry and considered as normal.
Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Other classification in USA and traded on New York Stock Exchange. It employs 22671 people.Dr Reddys Laboratories Limited (RDY) is traded on New York Stock Exchange in USA. It is located in INDIA and employs 22,671 people. Dr Reddys is listed under Pharmaceutical Products category by Fama And French industry classification.